| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |